InvestorsHub Logo

GD

Followers 25
Posts 863
Boards Moderated 0
Alias Born 07/12/2002

GD

Re: None

Friday, 01/29/2021 10:34:35 AM

Friday, January 29, 2021 10:34:35 AM

Post# of 43784
Here is another point not many know, biotech companies are
allowed by FDA to be informed if the interim look TLD is passed
the test for efficacy to stop the trial, but for reasons the trial
is to continue, purpose is to let the companies to get CMC ready
for NDA or BLA filing as long as the companies keep the information
to them self, it is obvious in AMRN's case, and it may true with
CVM here, IMO. That is why listening to companies conference call
is important, some how CEO's comments and the tone of speaking
may give out the hints, IMO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News